Clinical Trial Update: The Longitudinal CONQUER Study of Rare Neuroimmunologic Disorders

View source ↗

Summary

The longitudinal CONQUER study is a long-term clinical trial examining rare neuroimmunologic disorders, including Neuromyelitis Optica and related conditions; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuromyelitis Optica
• Neuromyelitis Optica Spectrum Disorder
• Optic Neuritis
• Transverse Myelitis

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorder | Status: ACTIVE_NOT_RECRUITING